Novo Nordisk

Novo Nordisk to Double China R&D Headcount
Seeking Alpha
Wed, 09/15/10 - 09:23 am
R&D
Novo Nordisk
China
Bristol-Myers Pays A Premium For Its Partner
Investopedia
Sat, 09/11/10 - 11:35 am
Bristol-Myers Squibb
ZymoGenetics
Merck Serono
Novo Nordisk
The 15 Highest-Yielding Pharma & Biotech Stocks
Motley Fool
Thu, 09/2/10 - 09:24 am
PDL Biopharma
Eli Lilly
Sanofi
GSK
Bristol-Myers Squibb
AstraZeneca
Pfizer
Merck
Novartis
JNJ
Abbott Laboratories
Pharmaceutical Product Development
Techne
Biovail
Novo Nordisk
Novo Nordisk To Test Victoza In Anti-Obesity - CEO
WSJ Online
Tue, 08/24/10 - 08:01 am
obesity
Novo Nordisk
Victoza
Novo Nordisk Sales Rep Loses Retaliation Lawsuit
Pharmalot
Tue, 08/10/10 - 09:52 am
Novo Nordisk
drug reps
sexual harassment
Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Bloomberg Businessweek
Fri, 07/30/10 - 10:55 am
Novo Nordisk
Eli Lilly
Novartis
Ascendis
M&A
Novo's Victoza drains new scrips from rivals
Fierce Pharma
Wed, 07/28/10 - 11:15 pm
Novo Nordisk
Victoza
diabetes
Byetta
Eli Lilly
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
diabetes
GSK
Avandia
Actos
Takeda
Merck
Januvia
Novo Nordisk
Victoza
Eli Lilly
Byetta
Amylin
Onglyza
AstraZeneca
Bristol-Myers Squibb
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
diabetes
Orexigen
Contrave
Avandia
GSK
Merck
Eli Lilly
Amylin
Novo Nordisk
JNJ
MannKind
Afrezza
Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week
Pharmaceutical Processing
Sat, 06/26/10 - 10:15 am
type 1 diabetes
Novo Nordisk
IDegAsp
diabetes
degludec
BOOST
Sanofi-Aventis Is `on Track' to Meet Diabetes Sales Targets, Chancel Says
Bloomberg
Thu, 06/24/10 - 08:41 am
Sanofi
diabetes
Lantus
Victoza
Novo Nordisk
Diabetes And Obesity Options Percolate At JNJ, Novo
Forbes
Wed, 06/23/10 - 09:07 am
obesity
Novo Nordisk
diabetes
JNJ
Ortho-McNeil-Janssen
Novo to restart obesity research on Victoza
Fierce Pharma
Tue, 06/22/10 - 11:21 am
Novo Nordisk
Victoza
obesity
Novo Nordisk Moving Above Resistance
Traders Huddle
Thu, 06/17/10 - 11:07 am
Novo Nordisk
Big Yields in Big Pharma
Yahoo/IndieResearch
Mon, 06/14/10 - 12:52 pm
Abbott Laboratories
AstraZeneca
Baxter International
GSK
Eli Lilly
Bristol-Myers Squibb
Pfizer
JNJ
Novo Nordisk
Launch of IMIDIA - An Innovative Medicines Initiative Project for Diabetes
Yahoo
Mon, 06/14/10 - 12:41 pm
IMIDIA
diabetes
AstraZeneca
Roche
Sanofi
Boehringer Ingelheim
Eli Lilly
Novartis
Novo Nordisk
A Post-Earnings Checkup on Teva Pharmaceutical Industries Limited
Learning Markets
Fri, 06/4/10 - 07:30 am
Teva Pharmaceuticals
earnings
Novo Nordisk
Shire
Allergan
Novo pulls drugs from Greece over price cuts
Reuters
Tue, 06/1/10 - 06:11 am
Novo Nordisk
Greece
insulin
Good News for Novo Nordisk
Yahoo/Zacks.com
Thu, 05/27/10 - 08:13 pm
Novo Nordisk
diabetes
Eli Lilly
Pfizer
Victoza
Canada

Pages